Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
23 hedge funds and large institutions have $10.6M invested in Zosano Pharma Corporation in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 23 → 23 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
62% less capital invested
Capital invested by funds: $28.2M → $10.6M (-$17.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Telemetry Investments
New York
|
+$217K |
| 2 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
+$57.9K |
| 3 |
HM
HealthCor Management
New York
|
+$55.7K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$46.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.3M |
| 2 |
NC
Nexthera Capital
New York
|
-$850K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$302K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$102K |
| 5 |
VF
Virtu Financial
New York
|
-$94K |
ZSAN Hedge Fund Activity: Q4 2018 in Review
23 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q4 2018, worth a combined $10.6M — down 62% from $28.2M a quarter earlier.
Fund positioning in ZSAN was balanced in Q4 2018: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 6 trimmed.
The largest buyer was Telemetry Investments, adding an estimated $217K. The largest seller was Vanguard Group, cutting an estimated $1.3M.
- 23 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $10.6M of Zosano Pharma Corporation stock for Q4 2018, down 62% quarter-over-quarter.
- 5 funds opened new Zosano Pharma Corporation positions in Q4 2018 and 5 closed out, a net change of 0 holders.
- The largest Zosano Pharma Corporation buyer in Q4 2018 was Telemetry Investments, an estimated $217K added.
- The largest Zosano Pharma Corporation seller in Q4 2018 was Vanguard Group, an estimated $1.3M sold.
Based on aggregated 13F filings for Q4 2018.